Comparing the effect of hyoscine and diazepam in management of true peripheral vertigo

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016100815640N5

Enrollment

Registered

2016-10-10

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

True peripheral vertigo. Other peripheral vertigo

Interventions

Intervention 1: administration of 5 mg hyoscine slow intravenously (intervention). Intervention 2: administration of 10 mg diazepam slow intravenously (control).

Treatment - Drugs

administration of 5 mg hyoscine slow intravenously (intervention)

administration of 10 mg diazepam slow intravenously (control)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-60 years old patients with clinical diagnosis of true peripheral vertigo Exclusion criteria: History of vertigo mitigation prophylaxis, allergy to hyoscine or diazepam, pregnancy, renal failure, breast feeding, recurrent vertigo

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of vertigo. Timepoint: before drug administration and also 1 and 2 hours after that. Method of measurement: Verbal quantitative scale.	—

Secondary

Measure	Time frame
Side effects. Timepoint: from starting drug administration until 2 hours after. Method of measurement: Serial physical exam.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Baratloo

Shahid Beheshti University of Medical Sciences

alirezabaratloo@gmail.com+98 21 2272 1155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026